A recent study has found a potential link between obstructive sleep apnoea (OSA) and an increased risk of developing Parkinson’s disease. OSA is a common sleep disorder characterized by interruptions in breathing during sleep, leading to poor sleep quality and daytime fatigue. The study, conducted by researchers, suggests that individuals with OSA may be more susceptible to developing Parkinson’s disease due to the impact of sleep disturbances on brain function. However, the researchers also found that continuous positive airway pressure (CPAP) therapy, which is commonly used to treat OSA, may help reduce the risk of developing Parkinson’s disease. CPAP therapy involves the use of a machine that delivers a steady stream of air through a mask worn during sleep, keeping the airways open and improving breathing patterns. By improving sleep quality and reducing the interruptions in breathing associated with OSA, CPAP therapy may potentially lower the risk of developing Parkinson’s disease in individuals with OSA. These findings highlight the importance of managing OSA effectively to not only improve sleep quality and overall health but also potentially reduce the risk of developing neurodegenerative diseases like Parkinson’s. Further research is needed to fully understand the relationship between OSA, CPAP therapy, and Parkinson’s disease, but these initial findings provide valuable insights into potential preventive strategies. Individuals with OSA are encouraged to seek treatment and discuss the possibility of CPAP therapy with their healthcare providers to reduce their risk of developing Parkinson’s disease.